Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts

Ashwani Khurana, Deok Jung-Beom, Xiaoping He, Sung Hoon Kim, Robert C. Busby, Laura Lorenzon, Massimo Villa, Alfonso Baldi, Julian R Molina, Matthew Philip Goetz, Vijayalakshmi Shridhar

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Sulfatase 2 (Sulf-2) has been previously shown to be upregulated in breast cancer. Sulf-2 removes sulfate moieties on heparan sulfate proteoglycans which in turn modulate heparin binding growth factor signaling. Here we report that matrix detachment resulted in decreased Sulf-2 expression in breast cancer cells and increased cleavage of poly ADP-ribose polymerase. Silencing of Sulf-2 promotes matrix detachment induced cell death in MCF10DCIS cells. In an attempt to identify Sulf-2 specific inhibitor, we found that proteasomal inhibitors such as MG132, Lactacystin and Bortezomib treatment abolished Sulf-2 expression in multiple breast cancer cell lines. Additionally, we show that Bortezomib treatment of MCF10DCIS cell xenografts in mouse mammary fat pads significantly reduced tumor size, caused massive apoptosis and more importantly reduced Sulf-2 levels in vivo. Finally, our immunohistochemistry analysis of Sulf-2 expression in cohort of patient derived breast tumors indicates that Sulf-2 is significantly upregulated in autologous metastatic lesions compared to primary tumors (p < 0.037, Pearson correlation, Chi-Square analysis). In all, our data suggest that Sulf-2 might play an important role in breast cancer progression from ductal carcinoma in situ into an invasive ductal carcinoma potentially by resisting cell death.

Original languageEnglish (US)
Pages (from-to)407-415
Number of pages9
JournalClinical and Experimental Metastasis
Volume30
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Sulfatases
Heterografts
Breast Neoplasms
Cell Line
Cell Death
Heparan Sulfate Proteoglycans
Ductal Carcinoma
Carcinoma, Intraductal, Noninfiltrating
Poly(ADP-ribose) Polymerases
Sulfates
Heparin
Adipose Tissue
Neoplasms
Intercellular Signaling Peptides and Proteins
Breast
Immunohistochemistry
Apoptosis

Keywords

  • Breast cancer
  • Growth factor
  • Sulfatase 2

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts. / Khurana, Ashwani; Jung-Beom, Deok; He, Xiaoping; Kim, Sung Hoon; Busby, Robert C.; Lorenzon, Laura; Villa, Massimo; Baldi, Alfonso; Molina, Julian R; Goetz, Matthew Philip; Shridhar, Vijayalakshmi.

In: Clinical and Experimental Metastasis, Vol. 30, No. 4, 04.2013, p. 407-415.

Research output: Contribution to journalArticle

Khurana, Ashwani ; Jung-Beom, Deok ; He, Xiaoping ; Kim, Sung Hoon ; Busby, Robert C. ; Lorenzon, Laura ; Villa, Massimo ; Baldi, Alfonso ; Molina, Julian R ; Goetz, Matthew Philip ; Shridhar, Vijayalakshmi. / Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts. In: Clinical and Experimental Metastasis. 2013 ; Vol. 30, No. 4. pp. 407-415.
@article{b083fb68bf8a4cf6876fe2689bc095c1,
title = "Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts",
abstract = "Sulfatase 2 (Sulf-2) has been previously shown to be upregulated in breast cancer. Sulf-2 removes sulfate moieties on heparan sulfate proteoglycans which in turn modulate heparin binding growth factor signaling. Here we report that matrix detachment resulted in decreased Sulf-2 expression in breast cancer cells and increased cleavage of poly ADP-ribose polymerase. Silencing of Sulf-2 promotes matrix detachment induced cell death in MCF10DCIS cells. In an attempt to identify Sulf-2 specific inhibitor, we found that proteasomal inhibitors such as MG132, Lactacystin and Bortezomib treatment abolished Sulf-2 expression in multiple breast cancer cell lines. Additionally, we show that Bortezomib treatment of MCF10DCIS cell xenografts in mouse mammary fat pads significantly reduced tumor size, caused massive apoptosis and more importantly reduced Sulf-2 levels in vivo. Finally, our immunohistochemistry analysis of Sulf-2 expression in cohort of patient derived breast tumors indicates that Sulf-2 is significantly upregulated in autologous metastatic lesions compared to primary tumors (p < 0.037, Pearson correlation, Chi-Square analysis). In all, our data suggest that Sulf-2 might play an important role in breast cancer progression from ductal carcinoma in situ into an invasive ductal carcinoma potentially by resisting cell death.",
keywords = "Breast cancer, Growth factor, Sulfatase 2",
author = "Ashwani Khurana and Deok Jung-Beom and Xiaoping He and Kim, {Sung Hoon} and Busby, {Robert C.} and Laura Lorenzon and Massimo Villa and Alfonso Baldi and Molina, {Julian R} and Goetz, {Matthew Philip} and Vijayalakshmi Shridhar",
year = "2013",
month = "4",
doi = "10.1007/s10585-012-9546-5",
language = "English (US)",
volume = "30",
pages = "407--415",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts

AU - Khurana, Ashwani

AU - Jung-Beom, Deok

AU - He, Xiaoping

AU - Kim, Sung Hoon

AU - Busby, Robert C.

AU - Lorenzon, Laura

AU - Villa, Massimo

AU - Baldi, Alfonso

AU - Molina, Julian R

AU - Goetz, Matthew Philip

AU - Shridhar, Vijayalakshmi

PY - 2013/4

Y1 - 2013/4

N2 - Sulfatase 2 (Sulf-2) has been previously shown to be upregulated in breast cancer. Sulf-2 removes sulfate moieties on heparan sulfate proteoglycans which in turn modulate heparin binding growth factor signaling. Here we report that matrix detachment resulted in decreased Sulf-2 expression in breast cancer cells and increased cleavage of poly ADP-ribose polymerase. Silencing of Sulf-2 promotes matrix detachment induced cell death in MCF10DCIS cells. In an attempt to identify Sulf-2 specific inhibitor, we found that proteasomal inhibitors such as MG132, Lactacystin and Bortezomib treatment abolished Sulf-2 expression in multiple breast cancer cell lines. Additionally, we show that Bortezomib treatment of MCF10DCIS cell xenografts in mouse mammary fat pads significantly reduced tumor size, caused massive apoptosis and more importantly reduced Sulf-2 levels in vivo. Finally, our immunohistochemistry analysis of Sulf-2 expression in cohort of patient derived breast tumors indicates that Sulf-2 is significantly upregulated in autologous metastatic lesions compared to primary tumors (p < 0.037, Pearson correlation, Chi-Square analysis). In all, our data suggest that Sulf-2 might play an important role in breast cancer progression from ductal carcinoma in situ into an invasive ductal carcinoma potentially by resisting cell death.

AB - Sulfatase 2 (Sulf-2) has been previously shown to be upregulated in breast cancer. Sulf-2 removes sulfate moieties on heparan sulfate proteoglycans which in turn modulate heparin binding growth factor signaling. Here we report that matrix detachment resulted in decreased Sulf-2 expression in breast cancer cells and increased cleavage of poly ADP-ribose polymerase. Silencing of Sulf-2 promotes matrix detachment induced cell death in MCF10DCIS cells. In an attempt to identify Sulf-2 specific inhibitor, we found that proteasomal inhibitors such as MG132, Lactacystin and Bortezomib treatment abolished Sulf-2 expression in multiple breast cancer cell lines. Additionally, we show that Bortezomib treatment of MCF10DCIS cell xenografts in mouse mammary fat pads significantly reduced tumor size, caused massive apoptosis and more importantly reduced Sulf-2 levels in vivo. Finally, our immunohistochemistry analysis of Sulf-2 expression in cohort of patient derived breast tumors indicates that Sulf-2 is significantly upregulated in autologous metastatic lesions compared to primary tumors (p < 0.037, Pearson correlation, Chi-Square analysis). In all, our data suggest that Sulf-2 might play an important role in breast cancer progression from ductal carcinoma in situ into an invasive ductal carcinoma potentially by resisting cell death.

KW - Breast cancer

KW - Growth factor

KW - Sulfatase 2

UR - http://www.scopus.com/inward/record.url?scp=84876469098&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876469098&partnerID=8YFLogxK

U2 - 10.1007/s10585-012-9546-5

DO - 10.1007/s10585-012-9546-5

M3 - Article

C2 - 23412907

AN - SCOPUS:84876469098

VL - 30

SP - 407

EP - 415

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 4

ER -